Parenteral amphotericin B: fatal overdose risk due to confusion between lipid-based and non-lipid-based formulations

There is a potential risk of fatal overdose due to confusion between lipid-based and non-lipid-based formulations of parenteral amphotericin B. These formulations are not interchangeable: prescribers, pharmacists, and nurses need to be fully aware of the formulation being used and the associated dose regimen